Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Vaccine (2)
141 Articles Available
2
6
Can't find what you're looking for? Try our
advanced search
.
Vaccine
Merck Announces Positive Topline Results from Two Phase 3 Adult Studies Evaluating Pneumococcal Conjugate Vaccine
COVID-19 Vaccine
Pfizer and BioNTech Announce Data from Preclinical Studies of COVID-19 Vaccine Candidate
PR-M09-20-NI-15
AstraZeneca, Oxford SARS-CoV-2 Vaccine Trials Temporarily Paused
PR-M09-20-NI-11
COVID-19 Vaccine Supply
CSL to Manufacture and Supply University of Queensland and Oxford University Vaccine Candidates for Australia
PR-M09-20-NI-10
COVID-19 Vaccine
AMRI Selected to Support AstraZeneca in Delivery of COVID-19 Vaccine
PR-M09-20-NI-08
COVID-19
CureVac Expected to Receive up to 252 million Euros from the German Federal Ministry of Research for Further COVID-19 Vaccine Development
PR-M09-20-NI-05
COVID-19 Vaccine
Moderna Confirms Advanced Discussions with European Commission to Supply Europe with 80 Million Doses of mRNA Vaccine Against COVID-19
PR-M08-20-NI-42
COVID-19 Vaccine
Catalent Signs Agreement with AstraZeneca to Expand Manufacturing Support for COVID-19 Vaccine AZD1222
PR-M08-20-NI-41
Vaccine
European Commission Concludes Further Talks to Secure J&J COVID-19 Vaccine
PR-M08-20-NI-24
COVID-19 Vaccine
Intravacc and Celonic to Develop and Produce a Novel COVID-19 Vaccine
PR-M08-20-NI-03
COVID-19 Vaccine
Moderna Begins Phase 3 COVE Study of mRNA Vaccine Against COVID-19
PR-M07-20-NI-39
COVID-19 Vaccine
Pfizer and BioNTech Report T Cell Response in COVID-19 Vaccine
PR-M07-20-NI-30
HIV Prevention
Johnson & Johnson and Its Partners Mark a Milestone in the Quest for a Global Preventive HIV Vaccine with the Imbokodo Study
PR-M07-20-NI-026
Osivax Receives Over EUR 30M in Public Funding to Support Development of Universal Coronavirus and Influenza Vaccines
PR-M07-20-NI-010
COVID-19 Vaccine Collaboration
GSK and Medicago Announce Collaboration to Develop a Novel Adjuvanted COVID-19 Candidate Vaccine
PR-M07-20-NI-009
COVID-19 Vaccine Manufacturing
Emergent BioSolutions Signs Five-Year Agreement for Large-Scale Drug Substance Manufacturing for Johnson & Johnson’s Lead COVID-19 Vaccine Candidate
PR-M07-20-NI-007
Vaccine Production
Tesla to Make Molecule Printers for German COVID-19 Vaccine Developer CureVac
PR-M07-20-NI-002
COVID-19 Vaccine
Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2
PR-M06-20-NI-042
FDA
FDA Takes Action to Help Facilitate Timely Development of Safe, Effective COVID-19 Vaccines
PR-M06-20-NI-041
Immunotherapy
Applying the Principles of Immunotherapy to Infectious Diseases
PAP-Q2-20-CL-018
Coping with COVID-19
COVID-19: Understanding the Virus, the Pandemic, and the Path Forward
PAP-Q2-20-NI-004
COVID-19
Q: What is your perspective on how the pharma industry has responded to the COVID-19 pandemic? What lessons have been learned?
PAP-Q2-20-RT-001
COVID-19
INOVIO Announces Positive Interim Phase 1 Data For INO-4800 Vaccine for COVID-19
PR-M06-20-NI-039
Vaccine Manufacturing
Daiichi Sankyo Announces Start of Discussions with AstraZeneca Regarding Supply in Japan of Novel Coronavirus Vaccine
PR-M06-20-NI-036
«
2
6
»
.svg)